An important nuance is that, within the subset of recipients with type 1 diabetes and a leaner phenotype, SRTR did identify a statistically significant survival advantage for simultaneous transplantation, whereas TriNetX showed a trend in the same direction but without reaching statistical significance.
← all excerpts
Simultaneous Pancreas-Kidney Transplantation versus Kidney Alone: Interpreting Neutral Survival and Persistent Metabolic Advantages.
1
—
—